Peripheral biomarkers to assess risk, severity, and prognosis of immune checkpoint inhibitor-associated myocarditis: a retrospective clinical study
Surveillance of these economical biomarkers during ICI therapy might contribute to the risk prediction of ICI myocarditis, as well as the assessment of disease severity and prognosis.
Authors
- Zhenli Li (ORCID: https://orcid.org/0000-0002-3682-164X)
- Lingfei Guo (ORCID: https://orcid.org/0000-0002-4885-625X)
- Tiezhu Yao (ORCID: https://orcid.org/0000-0002-2851-2812)
- Jing Liu (ORCID: https://orcid.org/0000-0002-3113-4015)
- Guang Liu (ORCID: https://orcid.org/0000-0003-0468-1061)
- Zhengkun Guan
- Jingtao Ma
Institutions
- Hebei Medical University (CN)
- Fourth Hospital of Hebei Medical University (CN)
Publication Details
- Journal
- Frontiers in Cardiovascular Medicine
- Published
- 2024-10-24
- DOI
- https://doi.org/10.3389/fcvm.2024.1465743
- Citations
- 4
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 1.13
Funders
- Hebei Medical University